HKEX Stock Code: 01093English|繁體|简体

2025 Annual Results

  • Revenue RMB26,006M, -10.4%
  • Reported profit attributable to shareholders of the Company RMB3,882M, -10.3%
  • Underlying profit attributable to shareholders of the Company RMB3,534M, -24.5%
  • Basic earnings per share (based on reported profit) RMB33.98 cents, -7.8%

Highlight - 2025 Annual Results

Revenue
RMB26,006M, -10.4%
Reported profit attributable to shareholders of the Company
RMB3,882M, -10.3%
Underlying profit attributable to shareholders of the Company
RMB3,534M, -24.5%
Basic earnings per share (based on reported profit)
RMB33.98 cents, -7.8%

Corporate Governance

Corporate Governance

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2026 CSPC Pharmaceutical Group Limited. All Rights Reserved.